Raju Rebekah, Prasad Arya S, S Rajesh Kumar
Department of Orthodontics and Dentofacial Orthopaedics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Cureus. 2024 Aug 25;16(8):e67708. doi: 10.7759/cureus.67708. eCollection 2024 Aug.
Introduction Silver nanoparticles have been the most commonly used nanoparticles which could be integrated with plant extracts. The mutually beneficial interaction between neutral plant extracts and nanoparticles reduced the chemical toxicity while promoting synthesis. Azadirachta indica, widely known as the neem plant, has diverse medicinal compounds encompassing antibacterial, antiviral, antiprotozoal, insecticidal, antifungal, and antioxidant properties. Swertia chirata, known as Chirayata in India, stands out for its dual roles as a laxative and appetiser with pronounced antimicrobial and anti-inflammatory qualities. Hence, this study aimed to evaluate the anti-inflammatory and antioxidant properties of silver nanoparticles synthesized using Neem and Kirata extract. Materials and methods The plant extracts of Neem (Azadirachta indica) and Kirata (Swertia chirata) were obtained in powder form. It was later formulated into an extract and stored in a refrigerator at 4 degrees Celsius. The formulated extract of Neem and Kirata was then incorporated with silver nitrate to form a modified silver nanoparticle using a green synthesis approach. The anti-inflammatory activity of Neem and Kirata extract was tested using Bovine Serum Assay and Egg Albumin Assay. The antioxidant activity of the new herbal-formulated Ag nanoparticles was determined by the DPPH ((2,2-diphenyl-1-picrylhydrazyl) assay. Results Based on the anti-inflammatory assays, the Neem and Kirata-induced nanoparticles showed increasing levels of inhibition, while the standard showed slightly higher inhibition at 10, 20 and 30 µL. At 40 µL and 50 µL, both Kirata and Neem (Ag) and the standard showed high levels of inhibition, nearing 75% and above, with the standard consistently showing a marginally higher inhibition percentage. Based on the DPPH assay, the Neem Kirata-induced Ag nanoparticle showed a comparable or slightly higher inhibition percentage compared to the standard. Conclusion The study underscores the potential of Neem and Kirata herbal-based silver nanoparticles as effective anti-inflammatory and antioxidant agents. Future research directions should focus on refining nanoparticle synthesis, investigating mechanisms of action, and exploring additional therapeutic applications in the biomedical and pharmaceutical sectors.
引言 银纳米颗粒是最常用的纳米颗粒,可与植物提取物结合。中性植物提取物与纳米颗粒之间的互利相互作用降低了化学毒性,同时促进了合成。印楝,广为人知的苦楝树,含有多种药用化合物,具有抗菌、抗病毒、抗原虫、杀虫、抗真菌和抗氧化特性。印度獐牙菜,在印度被称为奇拉塔,以其作为泻药和开胃剂的双重作用以及显著的抗菌和抗炎特性而闻名。因此,本研究旨在评估使用印楝和奇拉塔提取物合成的银纳米颗粒的抗炎和抗氧化特性。
材料和方法 印楝(Azadirachta indica)和奇拉塔(Swertia chirata)的植物提取物以粉末形式获得。随后将其配制成提取物并储存在4摄氏度的冰箱中。然后使用绿色合成方法将印楝和奇拉塔的配制提取物与硝酸银混合,形成改性银纳米颗粒。使用牛血清试验和蛋清试验测试印楝和奇拉塔提取物的抗炎活性。通过DPPH((2,2-二苯基-1-苦基肼)试验测定新型草药配方的银纳米颗粒的抗氧化活性。
结果 基于抗炎试验,印楝和奇拉塔诱导的纳米颗粒显示出抑制水平的增加,而标准品在10、20和30微升时显示出略高的抑制率。在40微升和50微升时,奇拉塔和印楝(银)以及标准品均显示出高水平的抑制,接近75%及以上,标准品始终显示出略高的抑制百分比。基于DPPH试验,印楝奇拉塔诱导的银纳米颗粒与标准品相比显示出相当或略高的抑制百分比。
结论 该研究强调了基于印楝和奇拉塔草药的银纳米颗粒作为有效的抗炎和抗氧化剂的潜力。未来的研究方向应集中在改进纳米颗粒合成、研究作用机制以及探索在生物医学和制药领域的其他治疗应用。